Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep Apnea: The ADIPOSA Study
Part of paid clinical trials in New Haven, Connecticut.
- Sponsor
- Yale University
- Study ID
- NCT05612594
- Phase
- PHASE4
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Bexagliflozin 20 mg — DRUG15mg once daily
- Placebo — DRUGmatching placebo once daily
Study Details
The goal of this clinical trial is to test if bexagliflozin lowers the sleep apnea severity in adults who are overweight or obese with moderate to severe obstructive sleep apnea (OSA) compared with a placebo (look-alike substance that contains no active drug). The main question it aims to answer is: * If SGLT2i will reduce anatomic and physiologic traits, clinical measures of OSA and sleep deficiency in participants * If improvement in clinical measures are because of improvement in the anatomic and physiologic traits. Participants will be placed on either drug or placebo and get routine normal care for 6 months. At the start and end of the study, participants will undergo different clinical measurements to see if the drug makes the sleep apnea better.
Key Dates
- Start date
- Mar 27, 2024
- Status verified
- Sep 2025
- Primary completion
- Sep 30, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 164 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: BexagliflozinBexagliflozin once daily for 6 months
- Placebo Comparator: PlaceboPlacebo once daily for 6 months
Primary Outcome Measure
Change in Apnea hypopnea index (AHI) measured by full ambulatory polysomnography (aPSG) [ Time Frame: Baseline and 6 months ]
Central Contacts
- Henry K Yaggi, M.D.203-785-4163
- Ian J Neeland, M.D.216-844-5965
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Yale New Haven Health | New Haven | Connecticut | 06520 | - |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | - |
Find similar trials in New Haven, CT
Related Studies
- Janus II FeasibilityRecruiting · Zoll Medical Corporation · Scottsdale, Arizona
- Continuous Positive Airway Pressure, Arousability and Links to Mechanisms in Obstructive Sleep ApneaPHASE3 · Recruiting · Yale University · North Haven, Connecticut
- Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep ApneaPHASE4 · Recruiting · University of South Florida · Tampa, Florida
- Sleep Apnea in ElderlyPHASE4 · Recruiting · VA Office of Research and Development · Detroit, Michigan